Diabetes Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Demand for medical devices has picked up pace as non-urgent procedures, which were deferred during the pandemic, recovered in the past year with easing hospital staff shortages and people becoming regular with check-ups. Medtronic expects adjusted profit for the fiscal 2024 to be between $5.19 and $5.21 per share, compared with its previous forecast range of $5.13 and $5.19 per share. Sales at the company's heart devices unit, its biggest revenue driver, increased 6.1% to $2.93 billion, versus analysts' estimate of $2.89 billion.

<p><em>New study finds that adolescent obesity significantly heightens the risk of developing early chronic kidney disease in young adulthood. Even those with high-normal BMI are at risk. Severe obesity poses the highest risk, but even mild obesity and being overweight contribute significantly to this increased risk for both males and females. Lowering obesity rates in adolescents is crucial to better managing the risk of kidney disease and subsequent cardiovascular issues. This study emphasizes the need for preventive measures and management of risk factors associated with chronic...

An early trial suggests that a drug commonly used for rheumatoid arthritis could reduce type 1 diabetics' reliance on insulin, but questions remain.

A trial comparing baricitinib against placebo in people with new-onset type 1 diabetes suggests use could contribute to the preservation of β-cell function.

A trial comparing baricitinib against placebo in people with new-onset type 1 diabetes suggests use could contribute to the preservation of β-cell function.